AKT1 and neoplasm: Other studies have shown that combination therapy using a HER2 monoclonal antibody and an Akt inhibitor inhibited growth of MMTV-NIC PTEN−/− tumours that were resistant to treatment with either drug alone (Wang et al., 2012).